ATHN CV

Enter your search criteria to find works by title, author, publication, keyword(s), or date.

Back

ATHN 16

Preliminary Analysis of ATHN 16: Real-World Safety of Eptacog Beta

Author(s):

Lauren Amos, Daniel Bonzo, Ashley Eason, Miguel Escobar, Christine Knoll, Philip Kurikose, Emmanuelle Lagrue, Sonia Nasr, Michael Recht, Spencer Sullivan, Doris Quon, Mark Reding
Publication:
ISTH 2023 Congress (poster)
Date:
June 24-28, 2023
Topics:
Hemophilia, Safety
Visit Publication

A Preliminary Analysis of ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors

Author(s):

Tammuella Chrisentery-Singleton, Lauren E Amos, Daniel Bonzo, Miguel Escobar, Adam Giermasz, Emmanuelle Lagrue, Christine Knoll, Sonia Nasr, Michael Recht, Spencer Sullivan, Doris V Quon, Mark T Reding
Publication:
Blood
Date:
November 15, 2022
Topics:
Safety, Eptacog-Beta
Visit Publication

ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):

Tammuella Chrisentery-Singleton, W Allan Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Michael U Callaghan, Miguel Escobar, Adam Giermasz, M Nikki Hirsh, Janna Journeycake, Sonia Nasr, Doris V Quon, Mark Reding, Michael Recht
Publication:
Thrombosis & Hemostasis Summit of North American 2022
Date:
August 17, 2022
Topics:
Adult treatments, AHP including (AIP)
Visit Publication

ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors, with or without Prophylactic Treatment

Author(s):

Tammuella Christenery-Singleton, W Allan Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Michael Callaghan, Miguel Escobar, Adam Giermasz, M Nikki Hirsh, Janna Journeycake, Sonia Nasr, Rajiv Pruthi, Doris Quon, Amina Rafique, Mark Reding, Spencer Sullivan, Michael Recht
Publication:
ISTH 2022 Congress
Date:
July 9-13, 2022
Topics:
Safety, Eptacog-Beta
Visit Publication

ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):

Michael Callaghan, W Allen Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Miguel Escobar, Adam Giermasz, Nikki Hirsh, Janna Journeycake, Sonia Nasr, Doris Quon, Tammuella Chrisentery-Singleton, Michael Recht
Publication:
Haemophilia
Date:
July 1, 2022
Topics:
Safety, Eptacog-Beta
Visit Publication

PO035 ATHN 16: Safety of Coagulation Factor VIIA (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):

Tammuella Chrisentery-Singleton, W Allan Alexander, Ahmad Al-Sabbagh, Miguel Escobar, Adam Giermasz, Janna Journeycake, Sonia Nasr, Doris Quon, Michael Recht, Daniel Bonzo, M Nikki Hirsh, Mark Reding, Michael Callaghan
Publication:
15th Annual Congress of EAHAD Virtual
Date:
February 2-4, 2022
Topics:
Chromogenic Method, Factor VIII, Antibody, Emicizumab
Visit Publication

ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):

Tammuella Chrisentery-Singleton, W Allen Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Michael U Callaghan, Miguel Escobar, Adam Giermasz, Nikki Hirsh, Janna Journeycake, Sonia Nasr, Doris V Quon, Michael Recht
Publication:
Blood
Date:
November 5, 2021
Topics:
Bleeding Events, Inhibitors, Prophylactic Treatment
Visit Publication

Safety of Coagulation Factor 7A (recombinant) for the Treatment of Bleeding Events in Patients with Hemophilia A or B

Author(s):

Nikki Hirsh, Janna Journeycake, Doris Quon, Tammuella Chrisentery-Singleton, Michael Recht
Publication:
HTRS 2021 Scientific Symposium
Date:
March 10-12, 2021
Topics:
Visit Publication

ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):

Michael Callaghan, W Allan Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Adam Giermasz, Nikki Hirsh, Janna Journeycake, Sonia Nasr, Doris Quon, Tammuella Chrisentery-Singleton, Michael Recht
Publication:
HTRS 2021 Scientific Symposium
Date:
March 10-12, 2021
Topics:
Scientific, Symposium, Virtual Conf. (2021)
Visit Publication

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.